http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EC-SP20029569-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f87b74704bc23c2bbc2d90d06672b15a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
filingDate 2020-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_942b9be867d36ab19e7a401f05c41366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c73f70443b1623088c6c7ed9b5d6adee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a722beb9feb48aec3f9f7ca97f032759
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce154c29b3a9f87799427b2bb4381f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25e24aedb00055577a5dc609c8270c90
publicationDate 2020-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EC-SP20029569-A
titleOfInvention NEW PYRAZOLO PIPERIDINE SUBSTITUTED INDOOL-2-CARBOXAMIDES, HIGH ACTIVITY, ACTIVE AGAINST HEPATITIS B VIRUS (HBV)
abstract The present invention relates, in general, to new antiviral agents. Specifically, the present invention relates to compounds that can inhibit the protein (s) encoded by the hepatitis B virus (HBV) or interfere with the function of the replication cycle of HBV, to compositions comprising these compounds, to methods for inhibiting the replication of the HBV virus, to methods for treating or preventing HBV infection, and to processes or intermediates for making the compounds.
priorityDate 2017-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20784738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422576911

Total number of triples: 28.